Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-016713
Filing Date
2004-03-19
Accepted
2004-03-19 16:49:19
Documents
1
Period of Report
2004-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6336
  Complete submission text file 0001209191-04-016713.txt   8370
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address MERCK MEDCO MANAGED CARE INC 100 SUMMIT AVE MONTVALE NJ 07645
Business Address MERCK MEDCO MANAGED CARE INC 100 SUMMIT AVE MONTVALE NJ 07645 2107823850
ATIEH MICHAEL G (Reporting) CIK: 0001072501 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 04680487